常规粪便标本中的艰难梭菌和细胞毒素
Clostridium difficile and cytotoxin in routine faecal specimens.
作者信息
Nash J Q, Chattopadhyay B, Honeycombe J, Tabaqchali S
出版信息
J Clin Pathol. 1982 May;35(5):561-5. doi: 10.1136/jcp.35.5.561.
Abstract
Over a five-month period 1239 unselected, routine faecal specimens from 856 patients were examined for Clostridium difficile. One hundred specimens representing 69 patients were culture-positive. Toxin was detected in the stool of ten. During the study period, there were 41 Salmonella, 12 Campylobacter and 9 Shigella infections. C difficile was isolated together with Salmonella from 12 patients. No patient required specific treatment for C difficile infection. The significance of these findings is discussed.
摘要
在五个月的时间里，对来自856名患者的1239份未经筛选的常规粪便标本进行了艰难梭菌检测。代表69名患者的100份标本培养呈阳性。在10人的粪便中检测到毒素。在研究期间，有41例沙门氏菌感染、12例弯曲杆菌感染和9例志贺氏菌感染。从12名患者中分离出艰难梭菌和沙门氏菌。没有患者因艰难梭菌感染而需要特殊治疗。讨论了这些发现的意义。
相似文献
1
Clostridium difficile and cytotoxin in routine faecal specimens.
J Clin Pathol. 1982 May;35(5):561-5. doi: 10.1136/jcp.35.5.561.
2
Usefulness of culture in the diagnosis of Clostridium difficile infection.
Eur J Clin Microbiol Infect Dis. 1995 Mar;14(3):223-6. doi: 10.1007/BF02310360.
3
Clostridium difficile cytotoxin in a pediatric population.
Am J Dis Child. 1983 Mar;137(3):271-4. doi: 10.1001/archpedi.1983.02140290057015.
4
Clostridium difficile and its cytotoxin in infants admitted to hospital with infectious gastroenteritis.
Br Med J (Clin Res Ed). 1984 Feb 18;288(6416):524-6. doi: 10.1136/bmj.288.6416.524.
5
Feacal carriage of cytotoxigenic strains of Clostridium difficile by adult Nigerians.
East Afr Med J. 1989 May;66(5):319-23.
6
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
Gastroenterology. 1981 Jul;81(1):5-9.
7
Clostridium difficile toxin in faecal specimens of healthy children and children with diarrhoea.
Acta Paediatr Scand. 1982 Mar;71(2):275-8. doi: 10.1111/j.1651-2227.1982.tb09414.x.
8
Clostridium difficile associated disease in Thailand.
Southeast Asian J Trop Med Public Health. 1990 Sep;21(3):367-72.
9
Occurrence and significance of Clostridium difficile in faecal specimens of hospitalized children.
Zentralbl Bakteriol Mikrobiol Hyg A. 1989 Jan;270(3):441-8. doi: 10.1016/s0176-6724(89)80014-8.
10
Clostridium difficile-associated diarrhoea.
J Infect. 1984 Mar;8(2):123-8. doi: 10.1016/s0163-4453(84)92443-5.
引用本文的文献
1
The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review.
Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1047-57. doi: 10.1007/s10096-016-2639-3. Epub 2016 Apr 23.
2
Clostridium difficile: clinical disease and diagnosis.
Clin Microbiol Rev. 1993 Jul;6(3):251-65. doi: 10.1128/CMR.6.3.251.
3
Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children.
Gut. 1994 Nov;35(11):1608-12. doi: 10.1136/gut.35.11.1608.
4
Asymptomatic neonatal colonisation by Clostridium difficile.
Arch Dis Child. 1984 May;59(5):466-72. doi: 10.1136/adc.59.5.466.
5
Intestinal colonization of infant hamsters with Clostridium difficile.
Infect Immun. 1983 Nov;42(2):480-6. doi: 10.1128/iai.42.2.480-486.1983.
6
A selective enrichment broth for the isolation of Clostridium difficile.
J Clin Pathol. 1984 Jan;37(1):98-9. doi: 10.1136/jcp.37.1.98.
7
Nosocomial diarrhoeas in a surgical division hyperendemic for Clostridium difficile: epidemiologic aspects emerging from an analysis of clinical records.
Eur J Epidemiol. 1986 Dec;2(4):272-81. doi: 10.1007/BF00419491.
8
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.
Infect Immun. 1986 Sep;53(3):573-81. doi: 10.1128/iai.53.3.573-581.1986.
9
Molecular studies on the epidemiology and pathogenicity of Clostridium difficile.
Gut. 1989 Nov;30 Spec No(Spec No):44-51. doi: 10.1136/gut.30.spec_no.44.
10
Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters.
Infect Immun. 1991 Apr;59(4):1223-30. doi: 10.1128/iai.59.4.1223-1230.1991.
本文引用的文献
1
Faecal toxin and severity of antibiotic-associated pseudomembranous colitis.
J Clin Pathol. 1981 May;34(5):548-51. doi: 10.1136/jcp.34.5.548.
2
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
Gastroenterology. 1981 Jul;81(1):5-9.
3
Clostridium difficile in relation to enteric bacterial pathogens.
J Clin Microbiol. 1980 Sep;12(3):297-300. doi: 10.1128/jcm.12.3.297-300.1980.
4
Antibiotic and pseudomembranous colitis.
J Antimicrob Chemother. 1981 Jun;7 Suppl A:53-65. doi: 10.1093/jac/7.suppl_a.53.
5
Bacterial interference between Clostridium difficile and normal fecal flora.
J Infect Dis. 1981 Mar;143(3):470-5. doi: 10.1093/infdis/143.3.470.
6
Relapsing pseudomembranous colitis associated with cancer chemotherapy.
J Infect Dis. 1981 Jun;143(6):865. doi: 10.1093/infdis/143.6.865.
7
Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease?
Lancet. 1980 Feb 23;1(8165):383-4. doi: 10.1016/s0140-6736(80)90940-x.
8
Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease.
Lancet. 1980 Feb 23;1(8165):381-3. doi: 10.1016/s0140-6736(80)90939-3.
9
Undescribed toxin in pseudomembranous colitis.
Br Med J. 1977 May 14;1(6071):1246-8. doi: 10.1136/bmj.1.6071.1246.
10
Identification of Clostridium difficile as a cause of pseudomembranous colitis.
Br Med J. 1978 Mar 18;1(6114):695. doi: 10.1136/bmj.1.6114.695.
Zotero 插件